Trial intelligence / Profile preview

Dichloroacetate (DCA) in MELAS Syndrome

NCT00068913Phase 2Unknown

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Mar 2000
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dichloroacetate in mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Status: unknown.

02

Drugs

dichloroacetate
03

Conditions

mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes (MELAS)

Beyond the preview

Go deeper on NCT00068913.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00068913.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call